Tenet Healthcare Corporation (THC) Stock Price Today
Aura AI Summary
Key Stats
- $21.50BMarket Cap
- -Volume
- HealthSector
- $267.0552W High
- $161.3752W Low
- -Typical Hold Time
- $32.58BEnterprise Value
- -Div Yield
- -Trading Activity
Track Tenet Healthcare Corporation (THC) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Tenet Healthcare Corporation has traded between a low of $161.37 and a high of $267.58, highlighting its annual price range. Buy and sell Tenet Healthcare Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Most Recent News
Life360 director Morin Brit sells 15,582 shares for $1 million
Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...
AbCellera's stock jumps after successful menopause drug trial and CFO insider buying.
AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...
Airbus leads aerospace market with strong orders despite production challenges
Airbus is outperforming Boeing in commercial aircraft orders, securing 821 net orders in H1 2026 compared to Boeing's 408. Morgan Stanley maintains an "Overweight" rating on Airbus, raising its price target to €255, reflecting confidence in the compa...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.